[Some aspects of pathogenetic therapy of diabetic angiopathies].
Efimov
A S
AS
Skrobonskaia
N A
NA
Karabun
P M
PM
Danilova
A I
AI
Zubkova
S T
ST
Naumenko
V G
VG
Mankovskiĭ
B N
BN
Melńik
I M
IM
Malik
A
A
Tkachuk
Iu V
IuV
D045930:Anabolic Agents / Q000627:therapeutic use*; D000925:Anticoagulants / Q000627:therapeutic use*; D001402:B-Lymphocytes / Q000637:transplantation*; D003925:Diabetic Angiopathies / Q000209:etiology / Q000378:metabolism / Q000628:therapy*; D003928:Diabetic Nephropathies / Q000209:etiology / Q000378:metabolism / Q000628:therapy; D003930:Diabetic Retinopathy / Q000209:etiology / Q000378:metabolism / Q000628:therapy; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D015227:Lipid Peroxidation; D010179:Pancreas / Q000166:cytology
D045930:Anabolic Agents; D000925:Anticoagulants; D007004:Hypoglycemic Agents
Nekotorye aspekty patogeneticheskoĭ terapii diabeticheskikh angiopatiĭ.